NO963854D0 - Okulart spenningsnedsettende middel - Google Patents

Okulart spenningsnedsettende middel

Info

Publication number
NO963854D0
NO963854D0 NO963854A NO963854A NO963854D0 NO 963854 D0 NO963854 D0 NO 963854D0 NO 963854 A NO963854 A NO 963854A NO 963854 A NO963854 A NO 963854A NO 963854 D0 NO963854 D0 NO 963854D0
Authority
NO
Norway
Prior art keywords
group
alkyl
formula
alkenyl
carboxyl
Prior art date
Application number
NO963854A
Other languages
English (en)
Other versions
NO311068B1 (no
NO963854L (no
Inventor
Tomihisa Yokoyama
Tsunemichi Hosokawa
Hiroaki Yanagisawa
Original Assignee
Sankyo Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sankyo Co filed Critical Sankyo Co
Publication of NO963854D0 publication Critical patent/NO963854D0/no
Publication of NO963854L publication Critical patent/NO963854L/no
Publication of NO311068B1 publication Critical patent/NO311068B1/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/415—1,2-Diazoles
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • C07D233/64—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with substituted hydrocarbon radicals attached to ring carbon atoms, e.g. histidine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A61P27/06—Antiglaucoma agents or miotics
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • C07D233/66—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D233/90—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/10—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a carbon chain containing aromatic rings

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Ophthalmology & Optometry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Steroid Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Materials For Medical Uses (AREA)
NO19963854A 1994-03-16 1996-09-13 Anvendelse av imidazolforbindelser for fremstilling av et medikament for behandling av okular hypertensjon og/eller glaukom NO311068B1 (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP4540494 1994-03-16
PCT/JP1995/000444 WO1995024902A1 (fr) 1994-03-16 1995-03-16 Reducteur de tension oculaire

Publications (3)

Publication Number Publication Date
NO963854D0 true NO963854D0 (no) 1996-09-13
NO963854L NO963854L (no) 1996-11-14
NO311068B1 NO311068B1 (no) 2001-10-08

Family

ID=12718322

Family Applications (1)

Application Number Title Priority Date Filing Date
NO19963854A NO311068B1 (no) 1994-03-16 1996-09-13 Anvendelse av imidazolforbindelser for fremstilling av et medikament for behandling av okular hypertensjon og/eller glaukom

Country Status (20)

Country Link
US (1) US5925664A (no)
EP (2) EP1110551B1 (no)
KR (1) KR100211446B1 (no)
CN (2) CN1104898C (no)
AT (2) ATE206050T1 (no)
AU (1) AU684916B2 (no)
CZ (1) CZ284395B6 (no)
DE (2) DE69533045T2 (no)
DK (2) DK1110551T3 (no)
ES (2) ES2163501T3 (no)
FI (2) FI114897B (no)
GR (1) GR3036989T3 (no)
HK (1) HK1000551A1 (no)
HU (1) HUT74734A (no)
MX (1) MX9604109A (no)
NO (1) NO311068B1 (no)
NZ (1) NZ282485A (no)
PT (2) PT1110551E (no)
RU (1) RU2123847C1 (no)
WO (1) WO1995024902A1 (no)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
HUP0201466A3 (en) * 1999-06-11 2003-04-28 Sankyo Co Ocular tension lowering composition for topical administration
JP4000505B2 (ja) * 1999-12-01 2007-10-31 第一三共株式会社 緑内障を治療するための併用剤
GR20000100281A (el) * 2000-08-17 2002-05-24 Ιωαννης Ματσουκας Ανταγωνιστες του υποδοχεα της αγγεοτενσινης ιι και συνθετικες μεθοδοι για την θεραπεια της υπερτασης και καρδιοαγγειακων ασθενειων
AU2002218527A1 (en) * 2000-12-05 2002-06-18 Sankyo Company Limited Ocular tension-lowering compositions for topical administration
CN1798576B (zh) * 2003-04-15 2012-09-26 三共株式会社 预防或治疗眼内血管新生性疾病的药物

Family Cites Families (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA1334092C (en) * 1986-07-11 1995-01-24 David John Carini Angiotensin ii receptor blocking imidazoles
JPS6323868A (ja) * 1986-07-11 1988-02-01 イー・アイ・デュポン・ドゥ・ヌムール・アンド・カンパニー アンギオテンシン２受容体遮断性イミダゾ−ル
US5138069A (en) * 1986-07-11 1992-08-11 E. I. Du Pont De Nemours And Company Angiotensin II receptor blocking imidazoles
US4820843A (en) * 1987-05-22 1989-04-11 E. I. Du Pont De Nemours And Company Tetrazole intermediates to antihypertensive compounds
CA1338238C (en) * 1988-01-07 1996-04-09 David John Carini Angiotensin ii receptor blocking imidazoles and combinations thereof with diuretics and nsaids
DE69025473T2 (de) * 1989-06-30 1996-10-17 Du Pont Substituierte imidazole und ihre verwendung als hemmmstoff fur angiotensin ii
WO1991015206A1 (en) * 1990-04-05 1991-10-17 E.I. Du Pont De Nemours And Company Treatment of glaucoma and ocular hypertension with imidazole angiotensin-ii receptor antagonists
US5196444A (en) * 1990-04-27 1993-03-23 Takeda Chemical Industries, Ltd. 1-(cyclohexyloxycarbonyloxy)ethyl 2-ethoxy-1-[[2'-(1H-tetrazol-5-yl)biphenyl-4-yl]methyl]benzimidazole-7-carboxylate and compositions and methods of pharmaceutical use thereof
US5126342A (en) * 1990-10-01 1992-06-30 Merck & Co., Inc. Imidazole angiotensin ii antagonists incorporating acidic functional groups
IS1756B (is) * 1991-02-21 2000-12-28 Sankyo Company Limited Hliðstæðuaðferð til framleiðslu 1-Biphenylmethylimidazole afleiða
US5616599A (en) * 1991-02-21 1997-04-01 Sankyo Company, Limited Angiotensin II antagosist 1-biphenylmethylimidazole compounds and their therapeutic use
US5219856A (en) * 1992-04-06 1993-06-15 E. I. Du Pont De Nemours And Company Angiotensin-II receptor blocking, heterocycle substituted imidazoles
DK0573218T3 (da) * 1992-06-02 2001-06-18 Sankyo Co 4-carboxyimidazolderivater som angiotensin-II antagonister og deres terapeutiske anvendelse
US5310929A (en) * 1992-08-06 1994-05-10 E. I. Du Pont De Nemours And Company Prodrugs of imidazole carboxylic acids as angiotensin II receptor antagonists
JP3501484B2 (ja) * 1992-12-17 2004-03-02 三共株式会社 ビフェニル誘導体
CZ154994A3 (en) * 1993-07-02 1995-09-13 Senju Pharma Co Visual hypotensive agent
ES2243933T3 (es) * 1994-02-08 2005-12-01 Novartis Ag Tratamiento de glaucoma normotensivo con antagonistas de angiotensina ii.

Also Published As

Publication number Publication date
CZ284395B6 (cs) 1998-11-11
MX9604109A (es) 1997-09-30
DE69533045D1 (de) 2004-06-17
FI20041236A (fi) 2004-09-24
DE69533045T2 (de) 2005-01-27
NZ282485A (en) 1997-06-24
CN1387846A (zh) 2003-01-01
FI115197B (fi) 2005-03-31
EP1110551A3 (en) 2001-08-16
DE69522955D1 (de) 2001-10-31
ATE206050T1 (de) 2001-10-15
RU2123847C1 (ru) 1998-12-27
DK1110551T3 (da) 2004-06-07
KR970701542A (ko) 1997-04-12
EP0795326A4 (no) 1997-09-17
DE69522955T2 (de) 2002-05-29
ATE266402T1 (de) 2004-05-15
KR100211446B1 (ko) 1999-08-02
PT795326E (pt) 2002-01-30
WO1995024902A1 (fr) 1995-09-21
EP0795326B1 (en) 2001-09-26
HUT74734A (en) 1997-02-28
CN1202819C (zh) 2005-05-25
AU684916B2 (en) 1998-01-08
AU1960295A (en) 1995-10-03
US5925664A (en) 1999-07-20
FI963645A (fi) 1996-11-14
ES2221872T3 (es) 2005-01-16
EP1110551A2 (en) 2001-06-27
FI114897B (fi) 2005-01-31
NO311068B1 (no) 2001-10-08
DK0795326T3 (da) 2001-11-26
HU9602534D0 (en) 1996-11-28
EP1110551B1 (en) 2004-05-12
NO963854L (no) 1996-11-14
GR3036989T3 (en) 2002-01-31
CN1148809A (zh) 1997-04-30
ES2163501T3 (es) 2002-02-01
CN1104898C (zh) 2003-04-09
HK1000551A1 (en) 2002-04-12
CZ269496A3 (en) 1996-12-11
EP0795326A1 (en) 1997-09-17
FI963645A0 (fi) 1996-09-16
PT1110551E (pt) 2004-07-30

Similar Documents

Publication Publication Date Title
DE69116909D1 (de) 3,5-Di-tertiärbutyl-4-hydroxyphenylmethylenderivate von 2-substituierten Thiazolidinonen, Oxazolidinonen und Imidazolidinonen als antientzündlich wirkende Mittel
ATE216584T1 (de) Xanthine-derivate als antidepressiva
ATE194335T1 (de) 4,5-diaryloxazol-derivate
ES2070186T3 (es) Nuevos derivados de 2,4-diamino-pirimidina-3-oxido y su utilizacion en la prevencion de la caida de los cabellos.
ATE134366T1 (de) Amid derivate von vitamin d
NO963854D0 (no) Okulart spenningsnedsettende middel
NO872874D0 (no) Amid-derivater.
NO893039L (no) Bruk av imidazopyrazol-derivater som analgesiske og antiinflammatoriske midler.

Legal Events

Date Code Title Description
MM1K Lapsed by not paying the annual fees